Infliximab, CAS [[170277-31-3]]

Produktübersicht

• Artikelname: Infliximab, CAS [[170277-31-3]]
• Artikelnummer: MCE-HY-P9970
• Hersteller Artikelnummer: HY-P9970
• Alternativnummer: MCE-HY-P9970-50MG,MCE-HY-P9970-25MG,MCE-HY-P9970-100MG,MCE-HY-P9970-1MG,MCE-HY-P9970-5MG,MCE-HY-P9970-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: Avakine, CT-P13, SB2, TA-650

Produktbeschreibung

Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-alpha. Infliximab prevents the interaction of TNF-alpha with TNF-alpha receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research[1][2]. The component ratio of this product is Active ingredient : Excipients = 9 : 47.

Produkteigenschaften

• Molekulargewicht: (145.98 kDa)
• Reinheit: 90.30
• CAS Nummer: [170277-31-3]
• Target-Kategorie: TNF Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies